Semin intervent Radiol 2017; 34(04): 307-312
DOI: 10.1055/s-0037-1608702
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Role of Palliative Care in Oncology

Rajiv Agarwal
1   Department of Medicine, Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
,
Andrew S. Epstein
2   Division of Solid Tumor Oncology, Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York
3   Department of Medicine, Palliative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
14 December 2017 (online)

Abstract

Palliative care is a powerful adjunct to oncology that adds distinct value to the physical, mental, and psychosocial well-being of patients living with cancer. Its expanding role and integration with standard oncologic care has proven clinical benefit, as the practice of palliative care can help alleviate symptom burden, enhance illness and prognostic understanding, and improve both the quality of life and overall survival for patients. The primary aim of this review article is to highlight the significant interplay between palliative care and oncology and, in doing so, shed light on the areas for improvement and modern challenges that exist to meet the complex palliative care needs of patients with cancer.

 
  • References

  • 1 Kelley AS, Morrison RS. Palliative care for the seriously ill. N Engl J Med 2015; 373 (08) 747-755
  • 2 Levy M, Smith T, Alvarez-Perez A. , et al. Palliative care version 1.2016. J Natl Compr Canc Netw 2016; 14 (01) 82-113
  • 3 American Academy of Hospice and Palliative Medicine; Center to Advance Palliative Care; Hospice and Palliative Nurses Association; Last Acts Partnership; National Hospice and Palliative Care Organization. National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for quality palliative care, executive summary. J Palliat Med 2004; 7 (05) 611-627
  • 4 Ferrell B, Connor SR, Cordes A. , et al; National Consensus Project for Quality Palliative Care Task Force Members. The national agenda for quality palliative care: the National Consensus Project and the National Quality Forum. J Pain Symptom Manage 2007; 33 (06) 737-744
  • 5 Basch E, Deal AM, Kris MG. , et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016; 34 (06) 557-565
  • 6 Denis F, Lethrosne C, Pourel N. , et al. Overall survival in patients with lung cancer using a web-application-guided follow-up compared to standard modalities: results of a phase III randomized trial. Abstract presented at the ASCO 2016 Annual Meeting; June 3–7, 2016: Chicago, IL
  • 7 Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002; 346 (14) 1061-1066
  • 8 Ayanian JZ, Chrischilles EA, Fletcher RH. , et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 2004; 22 (15) 2992-2996
  • 9 Malin JL, Ko C, Ayanian JZ. , et al. Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 2006; 14 (08) 837-848
  • 10 Weeks JC, Catalano PJ, Cronin A. , et al. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med 2012; 367 (17) 1616-1625
  • 11 Mack JW, Walling A, Dy S. , et al. Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer. Cancer 2015; 121 (11) 1891-1897
  • 12 Gramling R, Fiscella K, Xing G. , et al. Determinants of patient-oncologist prognostic discordance in advanced cancer. JAMA Oncol 2016; 2 (11) 1421-1426
  • 13 Epstein AS, Prigerson HG, O'Reilly EM, Maciejewski PK. Discussions of life expectancy and changes in illness understanding in patients with advanced cancer. J Clin Oncol 2016; 34 (20) 2398-2403
  • 14 Tanco K, Rhondali W, Perez-Cruz P. , et al. Patient perception of physician compassion after a more optimistic vs a less optimistic message: a randomized clinical trial. JAMA Oncol 2015; 1 (02) 176-183
  • 15 van Vliet LM, Epstein AS. Current state of the art and science of patient-clinician communication in progressive disease: patients' need to know and need to feel known. J Clin Oncol 2014; 32 (31) 3474-3478
  • 16 Temel JS, Greer JA, Admane S. , et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 2011; 29 (17) 2319-2326
  • 17 Morrison RS, Penrod JD, Cassel JB. , et al; Palliative Care Leadership Centers' Outcomes Group. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 2008; 168 (16) 1783-1790
  • 18 Zhang B, Wright AA, Huskamp HA. , et al. Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med 2009; 169 (05) 480-488
  • 19 Saito AM, Landrum MB, Neville BA, Ayanian JZ, Earle CC. The effect on survival of continuing chemotherapy to near death. BMC Palliat Care 2011; 10: 14
  • 20 Leong M, Shah M, Smith TJ. How to avoid late chemotherapy. J Oncol Pract 2016; 12 (12) 1208-1210
  • 21 Harrington SE, Smith TJ. The role of chemotherapy at the end of life: “when is enough, enough?”. JAMA 2008; 299 (22) 2667-2678
  • 22 Brumley R, Enguidanos S, Jamison P. , et al. Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc 2007; 55 (07) 993-1000
  • 23 Bakitas M, Lyons KD, Hegel MT. , et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 2009; 302 (07) 741-749
  • 24 Zimmermann C, Swami N, Krzyzanowska M. , et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014; 383 (9930): 1721-1730
  • 25 Temel JS, Greer JA, Muzikansky A. , et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363 (08) 733-742
  • 26 Temel JS, Greer JA, El-Jawahri A. , et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 2017; 35 (08) 834-841
  • 27 Ferrell BR, Temel JS, Temin S. , et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2017; 35 (01) 96-112
  • 28 Quill TE, Abernethy AP. Generalist plus specialist palliative care--creating a more sustainable model. N Engl J Med 2013; 368 (13) 1173-1175
  • 29 Kamal AH, Gradison M, Maguire JM, Taylor D, Abernethy AP. Quality measures for palliative care in patients with cancer: a systematic review. J Oncol Pract 2014; 10 (04) 281-287
  • 30 Bickel KE, McNiff K, Buss MK. , et al. Defining high-quality palliative care in oncology practice: an American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance Statement. J Oncol Pract 2016; 12 (09) e828-e838
  • 31 Hui D, Finlay E, Buss MK, Prommer EE, Bruera E. Palliative oncologists: specialists in the science and art of patient care. J Clin Oncol 2015; 33 (20) 2314-2317
  • 32 Committee on Approaching Death. Addressing Key End of Life Issues, Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington, DC: National Academies Press (US); 2015
  • 33 Hui D, Elsayem A, De la Cruz M. , et al. Availability and integration of palliative care at US cancer centers. JAMA 2010; 303 (11) 1054-1061
  • 34 Calton BA, Alvarez-Perez A, Portman DG, Ramchandran KJ, Sugalski J, Rabow MW. The current state of palliative care for patients cared for at leading US Cancer Centers: The 2015 NCCN Palliative Care Survey. J Natl Compr Canc Netw 2016; 14 (07) 859-866
  • 35 Hui D, Bansal S, Strasser F. , et al. Indicators of integration of oncology and palliative care programs: an international consensus. Ann Oncol 2015; 26 (09) 1953-1959
  • 36 Spetz J, Dudley N, Trupin L, Rogers M, Meier DE, Dumanovsky T. Few hospital palliative care programs meet national staffing recommendations. Health Aff (Millwood) 2016; 35 (09) 1690-1697
  • 37 Temel JS, Shaw AT, Greer JA. Challenge of prognostic uncertainty in the modern era of cancer therapeutics. J Clin Oncol 2016; JCO678573
  • 38 Roeland EJ. Tailoring palliative care to the changing needs of people facing cancer. J Clin Oncol 2017; 35 (08) 813-815
  • 39 Freireich EJ, Kurzrock R. The role of investigational therapy in management of patients with advanced metastatic malignancy. J Clin Oncol 2009; 27 (02) 304-306
  • 40 Schapira L, Moynihan TJ, von Gunten CF, Smith TJ. Phase I versus palliative care: striking the right balance. J Clin Oncol 2009; 27 (02) 307-308
  • 41 Hui D, Parsons H, Nguyen L. , et al. Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. Cancer 2010; 116 (18) 4402-4409
  • 42 Cheng JD, Hitt J, Koczwara B. , et al. Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 2000; 18 (02) 421-428
  • 43 Finlay E, Lu HL, Henderson HR, O'Dwyer PJ, Casarett DJ. Do phase 1 patients have greater needs for palliative care compared with other cancer patients?. Cancer 2009; 115 (02) 446-453
  • 44 Sun V, Cooke L, Chung V, Uman G, Smith TJ, Ferrell B. Feasibility of a palliative care intervention for cancer patients in Phase I clinical trials. J Palliat Med 2014; 17 (12) 1365-1368
  • 45 Levine DR, Johnson LM, Mandrell BN. , et al. Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancer. Cancer 2015; 121 (09) 1508-1512
  • 46 Ferrell BR, Chung VM, Koczywas M. , et al. Integration of palliative care for patients with solid tumors on phase I clinical trials. J Clin Oncol 2016; 34: 138
  • 47 Coldwell DM, Sewell PE. The expanding role of interventional radiology in the supportive care of the oncology patient: from diagnosis to therapy. Semin Oncol 2005; 32 (02) 169-173
  • 48 Tam A, Ahrar K. Palliative interventions for pain in cancer patients. Semin Intervent Radiol 2007; 24 (04) 419-429
  • 49 Chu L, Hawley P, Munk P, Mallinson P, Clarkson P. Minimally invasive palliative procedures in oncology: a review of a multidisciplinary collaboration. Support Care Cancer 2015; 23 (06) 1589-1596
  • 50 Fairchild AH, Rilling WS. Palliative interventional oncology. Cancer J 2016; 22 (06) 411-417
  • 51 Adam A, Kenny LM. Interventional oncology in multidisciplinary cancer treatment in the 21(st) century. Nat Rev Clin Oncol 2015; 12 (02) 105-113
  • 52 Campbell TC, Roenn JH. Palliative care for interventional radiology: an oncologist's perspective. Semin Intervent Radiol 2007; 24 (04) 375-381
  • 53 Daly ME, Riess JW. Multidisciplinary care. Cancer Treat Res 2016; 170: 285-300
  • 54 Monsky WL, Khorsand D, Nolan T, Douglas D, Khanna P. Quality of life assessment in interventional radiology. Acad Radiol 2014; 21 (03) 407-414
  • 55 McCullough HK, Bain RM, Clark HP, Requarth JA. The radiologist as a palliative care subspecialist: providing symptom relief when cure is not possible. AJR Am J Roentgenol 2011; 196 (02) 462-467
  • 56 Requarth JA. IR and palliative care: a good match. J Vasc Interv Radiol 2015; 26 (11) 1740-1741
  • 57 Dharmarajan KV, Wei R, Vapiwala N. Primary palliative care education in specialty oncology training: more work is needed. JAMA Oncol 2016; 2 (07) 858-859